Iryna Lebedinets

Iryna Lebedinets

Auto-generated profile, based on publicly available information

Iryna Lebedinets

National University of Pharmacy, Kharkiv, Ukraine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
PCPolina Chuykova
Polina Chuykova
ДШДіана Штриголь
Діана Штриголь
ATAndrii Taran
Andrii Taran
TYTetiana Yudkevych
Tetiana Yudkevych
ILIryna Lebedinets
Iryna Lebedinets
DODenys Oklei
Denys Oklei
Heat trauma (HT) is an urgent medical and social problem. Heat damage is a widespread effect of the environment on humans, driven by global warming, military conflicts, technological disasters, work in hot environments, and engagement in extreme sports and tourism. The aim of the study: to propose a model of acute HT in rats that does not cause the death of animals, to determine the dependence of thermoresistance on gender, and to compare the effectiveness of the thermoprotective effects of a range of non-steroidal anti-inflammatory drugs (NSAIDs), paracetamol, and glucosamine hydrochloride in this model. Materials and Methods: The experiment was conducted on adult white rats of both genders. Acute HT was modelled by using a specially developed method involving heat exposure to animals at +55 °C for 30 minutes, followed by a recovery period of 60 minutes. Rectal temperature was measured every 15 minutes. The degree of hyperthermia in males and females was determined. The presence and intensity of the thermoprotective effect of glucosamine hydrochloride (G h/ch), diclofenac sodium, acetylsalicylic acid (ASA), nimesulide, etoricoxib, celecoxib, and paracetamol were evaluated through intragastric administration 60 minutes before heat exposure. The results were analyzed using the STATISTICA 12.0 program. Results: It was established that heat exposure at +55 °C for 30 minutes effectively replicates acute HT in rats without causing animal fatalities, adhering to bioethical requirements. Body temperature increases by 10-13 %, characterized as a heat stroke. Occasionally, thermoresistant animals are encountered, where the temperature increase during the first 15 minutes of exposure is less than 1 °C. These animals should not be used for further modelling of heat trauma. Male rats are more sensitive to the effect of high environmental temperatures than females, exhibiting greater hyperthermia (temperature increase of 5.03±0.39°C compared to 3.72±0.22 °C in females, p<0.01). The thermoprotective effect of glucosamine hydrochloride depends on gender, being more pronounced in males. Among the 6 tested COX inhibitors, the most significant thermoprotective effect was observed in the highly selective COX-2 inhibitor celecoxib and the weakly selective central inhibitor paracetamol, warranting in-depth research into their impact on organ and system states following heat trauma, as well as the mechanisms of their thermoprotective action. The thermoprotective effect is not associated with selectivity towards COX (cyclooxygenase): it is not observed in the highly selective COX-2 inhibitor etoricoxib and moderately selective COX-2 inhibitor nimesulide, as well as in non-selective COX inhibitors such as diclofenac sodium and aspirin, which also slows down the recovery of body temperature after heat exposure. Conclusions: A convenient and simple model of acute HT in rats is proposed, demonstrating higher thermosensitivity and a more pronounced thermoprotective effect of glucosamine hydrochloride in males. A significant thermoprotective effect was identified in celecoxib and paracetamol, surpassing other investigated NSAIDs. The mechanism and specific features of this effect require further clarification

31 December 2023 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
ДШДіана Штриголь
Діана Штриголь
ATAndrii Taran
Andrii Taran
TYTetiana Yudkevych
Tetiana Yudkevych
DLDmytro Lytkin
Dmytro Lytkin
ILIryna Lebedinets
Iryna Lebedinets
OKOlga Koiro
Olga Koiro
Non-steroidal anti-inflammatory drugs (NSAIDs) have recently been considered promising agents for the prevention and treatment of cold injuries. The results of previous studies demonstrate a distinct frigoprotective effect of diclofenac sodium and etoricoxib. The aim of the study: to assess the impact of diclofenac sodium and etoricoxib, as the most effective frigoprotectors among NSAIDs, on coagulation indicators during the most acute phase of cold injuries using an acute model of general cooling in rats. Materials and Methods: The experiment was carried out using 41 outbreed male rats weighing 310±10 g. Cold injury was induced by acute general cooling (exposure to –18 °C for 2 hours). Diclofenac sodium (7 mg/kg) and etoricoxib (5 mg/kg) were administered intragastrically 30 minutes before the onset of cold exposure. Rectal temperature was measured before and after cold exposure. Immediately after exposure, plasma was used to determine prothrombin time (PT), thrombin time (TT), activated partial thromboplastin time (APTT), fibrinogen levels, and in blood serum – the residual amount of prothrombin, thrombin, fibrinogen, as well as D-dimer using species-specific immunoenzymatic analysis kits. Results: Etoricoxib and especially diclofenac sodium significantly reduced the degree of hypothermia (rectal temperature decreased by 1.3 % and 1.9 %, respectively, compared to a 5.4 % decrease in the control group, p < 0.05). In the acute phase of cold injury in the untreated control group, there was a significant increase in D-dimer (by 2.7 times) and fibrinogen content (by 1.9 times) in blood serum, alongside a 21.7 % increase in thrombin time, indicating a heightened risk of thrombus formation and DIC syndrome development. The other coagulation indicators did not show significant changes. Both diclofenac sodium and etoricoxib significantly reduced elevated D-dimer and serum fibrinogen, normalizing thrombin time and indicating an antithrombotic effect. There was no significant difference in the effect of both NSAIDs on blood coagulation status. Conclusions: The acute phase of cold injury demonstrates a dangerous shift in blood coagulation towards thrombus formation and DIC syndrome development. Prophylactic use of diclofenac sodium and, to a lesser extent, etoricoxib displays an anti-hypothermic effect, reducing the risk of thrombosis and DIC syndrome. This proves the expediency of using these NSAIDs for acute cold injury

28 March 2025 in Medicni perspektivi
Verified
Journal Article
Open access
PDF file
PCP.O. Chuykova
P.O. Chuykova
ДШДіана Штриголь
Діана Штриголь
ILI.O. Lebedynets
I.O. Lebedynets
DLD.V. Lytkin
D.V. Lytkin
Acute heat injury (AHI) occurs due to exposure to high environmental temperatures and is considered a dangerous condition that requires effective prevention and treatment. This underscores the importance of searching for and thoroughly studying thermoprotective agents. Previous studies on a rat model of AHI have shown that the highly selective cyclooxygenase-2 (COX-2) inhibitor celecoxib and the analgesic-antipyretic paracetamol effectively prevent hyperthermia, but celecoxib, unlike paracetamol, improves the functional state of the central nervous system during the recovery period. Since AHI induces blood coagulation disturbances, it is important to determine the effects of these thermoprotective agents on hemostasis. The aim of this study was to investigate the effects of paracetamol and celecoxib as effective thermoprotectors on coagulation parameters during the acute phase of heat trauma in rats. The AHI model was reproduced оn adult white male rats through a 30-minute exposure to +55°C. The animals were divided into four groups of 7-8 rats each: intact control, pathological control, celecoxib group (8.4 mg/kg intragastrically 50-60 minutes before heat exposure), and paracetamol group (125 mg/kg in the same regimen). Rectal temperature was monitored, and in rat plasma, fibrinogen, prothrombin time (PT), thrombin time (TT), activated partial thromboplastin time (APTT) were determined, while D-dimer was measured in serum. The results showed that during the acute phase of AHI in the pathological control group, when body temperature increased by an average of 4.33±0.33°C (p<0.01 compared to baseline), fibrinogen, PT, TT, and APTT levels remained unchanged, but the D-dimer level in serum increased by 2.2 times, indicating enhanced thrombogenesis. Both celecoxib and paracetamol exhibited a statistically significant thermoprotective effect (temperature rise of 3.16±0.40°C and 3.21±0.12°C, respectively, p<0.01 compared to untreated animals), had no effect on fibrinogen, PT, TT, or APTT levels, but normalized the D-dimer level, indicating an antithrombotic effect. The results justify the use of COX inhibitors, particularly celecoxib, in AHI.

30 June 2025 in Фармацевтичний часопис
Verified
Journal Article
Open access
PDF file
ПЧП. О. Чуйкова
П. О. Чуйкова
СШС. Ю. Штриголь
С. Ю. Штриголь
ТГТ. В. Горбач
Т. В. Горбач
ІЛІ. О. Лебединець
І. О. Лебединець
Мета роботи – з’ясувати вплив целекоксибу та парацетамолу на функціональний стан печінки та рівень оксидативного стресу в щурів на моделі гострої теплової травми. Матеріали і методи. Експеримент виконано на білих щурах-самцях. Гостру теплову травму моделювали шляхом 30-хвилинної експозиції за +55 °С. Оцінювали ректальну температуру, біохімічні маркери стану печінки в сироватки крові, вміст АТФ, показники пероксидного окиснення ліпідів (ПОЛ) та антиоксидантної системи (АОС) у печінці, коефіцієнт маси печінки. Парацетамол і целекоксиб вводили одноразово за 60 хв до теплового впливу. Результати та обговорення. У тварин контрольної патології спостерігали гіпертермію, гіперпротеїнемію внаслідок гемоконцентрації через зневоднення, зниження активності сироваткової гамма-глутамілтрансферази, зменшення рівня відновленого глутатіону, накопичення продуктів ПОЛ, зниження вмісту АТФ у печінці. Целекоксиб достовірно знижував температуру, повністю усував гіперпротеїнемію, нормалізував активність гамма-глутамілтрансферази та показники ПОЛ і АОС, сприяв підвищенню рівня АТФ. Парацетамол також зменшував гіпертермію, проте не повністю усував гіперпротеїнемію, погіршував прооксидантно-антиоксидантний баланс та не впливав на знижений вміст АТФ у печінці. Висновки. Целекоксиб за гострої теплової травми не лише зменшує ступінь гіпертермії, а й нормалізує вміст білка в крові, запобігає зменшенню активності гамма-глутамілтрансферази, знижує інтенсивність процесів ліпопероксидації у печінці та підтримує енергетичний обмін. Парацетамол попри антигіпертермічну дію не чинить аналогічного захисного впливу на досліджувані показники печінкового метаболізму.

31 March 2026 in Ukrainian Scientific Medical Youth Journal
Verified
Journal Article
Open access
MKMykola Komisarenko
Mykola Komisarenko
AMArtem Marchenko
Artem Marchenko
OMOlexander Maslov
Olexander Maslov
ILIryna Lebedinets
Iryna Lebedinets
TYTetiana Yudkevych
Tetiana Yudkevych
AKAlla Koval
Alla Koval
In recent years, increasing attention has been paid to natural compounds as potential therapeutic agents due to their broad spectrum of biological activities. Plant-derived compounds with antioxidant properties are of particular interest, as they may suppress pathological pathways. Therefore, the search for novel natural compounds capable of attenuating oxidative stress remains a promising area of biomedical research. The aim of this work was to evaluate the antioxidant potential of a thick blackberry fruit extract using in vitro, in vivo, and in silico molecular docking models. The study investigated a thick blackberry fruit extract. Docking simulations were performed using AutoDockTools 1.5.6. The antioxidant potential was assessed in vitro by the ferric reducing antioxidant potential (FRAP) assay, potentiometric method, and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay; in vivo, on mice via a carrageenan-induced paw edema assay. The in silico evaluation of antioxidant properties indicated that the major blackberry anthocyanins—cyanidin-3-glucoside, cyanidin-3-(3''-malonyl glucoside), and cyanidin-3-xyloside—blocked two out of three prooxidant targets. In contrast, cyanidin-3,3'-diglucoside and cyanidin-3-rutinoside blocked only one out of three targets, namely xanthine oxidoreductase. In vivo experiments revealed that administration of blackberry thick fruit extract at doses of 60.0 and 120.0 mg/kg possessed high antioxidant potential, where the extract significantly increased catalase levels to 51.31 ± 3.00 and 70.56 ± 3.40 μmol/min·L and decreased malondialdehyde (MDA) levels to 0.140 ± 0.016 and 0.120 ± 0.016 μmol/L in serum compared with the control group, respectively. Antioxidant profiling showed that the blackberry fruit extract exhibited the highest activity in the FRAP, potentiometric, and ABTS assays. According to the theoretical results, it was shown that due to the high content of anthocyanins in the blackberry fruit extract, the extract possesses the ability to inhibit crucial prooxidant enzymes. In vivo and in vitro models showed that the blackberry fruit extract demonstrated predicted interactions with enzyme targets relevant to oxidative stress.

31 March 2026 in News of Pharmacy
Verified
Journal Article
Open access
SPS. R. Petroshchuk
S. R. Petroshchuk
LDL. V. Derymedvid
L. V. Derymedvid
OMOlexander Maslov
Olexander Maslov
MKM. A. Komisarenko
M. A. Komisarenko
ILI. O. Lebedinets
I. O. Lebedinets
SKS. V. Kolisnyk
S. V. Kolisnyk
Aim. To assess the anti-inflammatory activity of a concentrated lingonberry fruit extract using the carrageenan-induced rat paw edema model, complemented by the molecular docking analysis. Materials and methods. The study object was a concentrated lingonberry fruit extract. Molecular docking analyses were conducted using AutoDockTools 1.5.6, and the anti-inflammatory activity was evaluated using the carrageenan-induced paw edema model in rats. Results. The theoretical assessment of the anti-inflammatory activity of the lingonberry fruit extract showed that lingonberry anthocyanins, such as cyanidin-3-galactoside, cyanidin-3-arabinoside, blocked three of them highly selectively, such as cyclooxygenase (COX-2), phospholipase A2 and 5-lipoxygenase (5-LOX), and medium-selective nuclear factor kappa B (NF-kB). No highly selective inhibitor was found among anthocyanins of NF-kB. At the same time, сyanidin-3-glucoside blocked three out four targets, such as COX-2, phospholipase A2, 5-LOX. Although the widely used reference compounds in medicine and research – the synthetic drug diclofenac sodium and the natural flavonoid quercetin – demonstrated the inhibitory activity against pro-inflammatory enzymes, their binding affinities were moderate to low. The molecular docking analysis showed the following binding energy values (kcal/mol) for diclofenac sodium and quercetin: COX-2 (–5.76 and –4.59), phospholipase A2 (–7.65 and –6.79), 5-LOX (–6.00 and –6.45), and NF-κB (–3.00 and –3.61), respectively. Experimental studies have shown a thick lingonberry fruit extract in the dose of 13.0 mg/kg (calculated with reference to the total anthocyanins expressed as cyanidin-3-glycoside) reduces edema in 1, 2, 3 and 4 hours by 45 %, 35 %, 25 % and 24 %compared to the control group, respectively. Conclusions. A comprehensive theoretical and experimental study of the anti-inflammatory properties of the lingonberry fruit extract has been conducted using the molecular docking analysis and the carrageenan-induced rat paw edema model in vivo. The results in silico demonstrated that lingonberry anthocyanins exhibited a strong binding affinity toward key pro-inflammatory targets, including COX-2, phospholipase A2, 5-LOX, and NF-κB. The findings in vivo showed that administration of a thick lingonberry fruit extract in the dose of 13.0 mg/kg (calculated with reference to the total anthocyanins expressed as cyanidin-3-glycoside) significantly inhibited inflammatory responses in all phases of the carrageenan-induced paw edema.